Por: RTTNews Health December 07, 2023
BrainStorm Cell Therapeutics, Inc. () announced Thursday the completion of a productive meeting with the U.S. Food and Drug Administration (FDA) to discuss NurOwn, its investigational treatment for amyotrophic lateral sclerosis (ALS).The primary objective of the meeting was to discuss key considerations for a Special Protocol Assessment (SPA) for a planned Phase 3b registrational trial for NurOwn.As an outcome of the meeting, BrainStorm will... + full article
ABC News USA Business September 28, 2023
WASHINGTON -- Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy.The panel of Food and Drug Administration experts voted 17-1... + más
What is ALS? Experts explain symptoms to look out for, causes and treatments | CBS News
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works | ABC News
ABC News USA Health September 28, 2023
CBS News USA Politics September 28, 2023
Federal health advisers voted overwhelmingly against an experimental treatment for at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy.The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm's... + más
WPLG Local 10 USA Health September 27, 2023
WASHINGTON – Federal health advisers voted overwhelmingly against an experimental treatment for Lou Gehrig’s disease at a Wednesday meeting prompted by years of patient efforts seeking access to the unproven therapy.The panel of Food and Drug Administration experts voted... + más
ABC News USA Health September 25, 2023
WASHINGTON -- The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a yearslong lobbying effort by patients with the fatal neurodegenerative disease.Those advocates still face one giant... + más
Experimental treatment pushed by ALS patients gets day before FDA, but agency unconvinced it works | WPLG Local 10
WPLG Local 10 USA Politics September 25, 2023
WASHINGTON – The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrig’s disease, the culmination of a by patients with the fatal neurodegenerative disease.Those advocates still face one giant hurdle: FDA regulators say... + más
CBS News USA Health August 08, 2023
Sandra Bullock's longtime partner at age 57 after privately battling ALS, or Amyotrophic Lateral Sclerosis, for three years, his family said. The news brought new attention to the disease and prompted questions about what the diagnosis means.ALS is a progressive... + más
NFL Playoff Scenarios | ABC News
Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate
About iurex | Privacy Policy | Disclaimer |